Internet Archive Scholar

Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations

Carolina Delgado-Martínez, Mariano Gómez-Rubio, Cecilia Gómez-Domínguez
2020 Annals of Hepatology  

Preserved Fulltext

Web Archive Capture PDF (2.2 MB)
https://web.archive.org/web/20200718082932/https://pdf.sciencedirectassets.com/321204/AIP/1-s2.0-S1665268120300727/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEEAaCXVzLWVhc3QtMSJIMEYCIQCxaA489iDCFBI5zV9jaKNHLd%2BKqEuy1%2FTfWXG7x%2FveNwIhAKc%2BL2ANK81caVZABYV4OYg3xRjsWp4vBYuDk0zrMj6kKr0DCOn%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQAxoMMDU5MDAzNTQ2ODY1IgwoXPVm17fCZjKKH7cqkQNyAy%2F8ZwbC0%2Fj72sYW8MtZW6OrTiP7a46YgC0muKtR8wzNhWIDiai0%2FfaInplERjuFmKMDlkbCkYuCm2BVE4kqMlga7zMMm1cKmbZg4Fvcj1TWcWl0UEBoQ%2B3%2BWB%2BwChjbfnkzzlxAlViNoi3a9Mvl2ii0zLaoxo38mGlCNwNybBs27zYegbmOM4%2F47wiRV3%2BuaNbYAgF6OPcjaYySXkvbNCP1s0FVBqkiU80Lt0A5YB%2FLAWmaUZh9DE%2Byht%2FjNv01UjGEnUf91OHD8oeSX3GgqapXC5wvZGjUm7kmhWDJpBlArfw847ZocEOmyYzOpbKVp054FMHkj1kRSDMPLq4yg%2BigY611h3jV4zmXYfEFSPBpm6CdDXd5C5TbMpliIZcPyhpVxWJ91g4NFTDieqllK%2FjRJR5E5EAxTBBu9WSg26BbvKWgRI3Y%2FoPxlN2Ma10X9dib5oj6BSQ3zzQ4Aciw9xYyzoUK%2BNwcp8w3veQ7hTL%2Fps2HD0hmKsz01ire0DJqX2nM54JSsIS4BE%2BehCKO3zCryMr4BTrqAV2t8Q59ifL1Uwo0O%2FZpHJjp1g4cTcPwvevCT4ESr5FkKZuot8w8mzp6vNOU4fUYK3u7xW2ePlOONKj%2F7mbSefc%2BtrKCVny9ju%2FfZ9Jx45rZnJwtgwM%2BTXxG3mSOvlY2Juv0kFrIig%2F7q0ZR96rcBPZL%2FgcCuocwn23ogb7RENlilMon7ey7B6fTaHnU6HV0I%2BqnMTj3K4NG3KLKuW4JOdRBNwvnQ5INvtHyuFG9zmIatQ26ELFZyhfVof44KSByO%2FraVbrJjyYkFX%2FkEz2m7w5hkXkuQ%2FKCtKExraZsqoyGWiW7bEXWcX%2Fyig%3D%3D&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20200718T082925Z&X-Amz-SignedHeaders=host&X-Amz-Expires=300&X-Amz-Credential=ASIAQ3PHCVTY3NVLEQTQ%2F20200718%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Signature=9b85a66c715dd29c98b83df941b250ca3875a5568c729ce6e086059ae83f10e0&hash=2b362b3782d61b677f841a47e66260d217cb8ca8f3f1b9274836053aab4ff76b&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S1665268120300727&tid=spdf-94f9a376-c8a2-42e3-97bf-2d3c152ec013&sid=f6de60714177d74c672951a0060f004108fegxrqa&type=client

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

The development of direct-acting antivirals (DAAs) has been a turning point in chronic hepatitis C treatment. With an efficacy rate on viral eradication close to 100% and an excellent safety profile, they have replaced interferon-based treatments as first-line therapy for hepatitis C virus (HCV). Following the encouraging results observed during the first years with these treatments, new publications suggested an unexpectedly high incidence of hepatocellular carcinoma (HCC) in patients
more » ... y treated with DAAs as well as a higher HCC recurrence rate in them. The possible interaction between DAAs and HCC and its impact on HCC incidence and recurrence still remains controversial. The aim of the present work is to review the current state of the matter by analyzing studies that evaluate the association between chronic hepatitis C treatment with DAAs and the development of HCC either de novo or as a recurrence. Following this, clinical practice recommendations are done.
doi:10.1016/j.aohep.2020.05.007 pmid:32687878 fatcat:3scqxrw56raonbfdo73odekb7a
DOAJ SciELO
Citation

Carolina Delgado-Martínez, Mariano Gómez-Rubio, Cecilia Gómez-Domínguez. "Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations." Annals of Hepatology (2020)